How many insider trades does FilingIQ track for BOLD?

FilingIQ tracks 376 Form 4 insider transactions for BOLD (Audentes Therapeutics, Inc.), covering filings from Jul 25, 2016 onwards. 0 of those were filed in the last 90 days.

Are BOLD insiders net buyers or net sellers?

Across the full Form 4 history for BOLD, 20 transactions (5%) were open-market purchases and 131 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BOLD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BOLD in?

Audentes Therapeutics, Inc. (BOLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $24.87M.

BOLD insider trading

NasdaqGS Healthcare

Audentes Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

376

Last 90 days

Buys / sells

5% / 35%

Market cap

$24.87M

About Audentes Therapeutics, Inc.

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Company website: boundlessbio.com

BOLD insider activity at a glance

FilingIQ has scored 376 insider transactions for BOLD since Jul 25, 2016. The most recent filing in our index is dated Jan 23, 2026.

Across the full history, 20 open-market purchases and 131 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BOLD insider trades is 47.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BOLD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for BOLD?: FilingIQ tracks 376 Form 4 insider transactions for BOLD (Audentes Therapeutics, Inc.), covering filings from Jul 25, 2016 onwards. 0 of those were filed in the last 90 days.
Are BOLD insiders net buyers or net sellers?: Across the full Form 4 history for BOLD, 20 transactions (5%) were open-market purchases and 131 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BOLD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BOLD in?: Audentes Therapeutics, Inc. (BOLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $24.87M.

Methodology & sources

Every BOLD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.